osimertinib
astrazeneca
['tagrisso', 'adaura', 'nsclc', 'sclc', 'aura ,(-laura)', 'astrazeneca']
at #asco23, gets practice-changing data from adaura study of tagrisso in egfr+ #nsclc #oncology 
https://t.co/O0ZJQGuINh, and its digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate